Baby aspirin? Many doctors don't recommend, despite guidelines

August 5, 2014
Baby aspirin? Many doctors don't recommend, despite guidelines

A majority of middle-aged men and women eligible to take aspirin to prevent heart attack and stroke do not recall their doctors ever telling them to do so, according to a University of Rochester study of a national sample of more than 3,000 patients.

Published online by the Journal of General Internal Medicine, the finding illustrates a common disconnect between public health guidelines and what occurs in clinical practice. The UR study is consistent with other research showing that physicians often do not recommend as prevention therapy to the general population, despite established guidelines by the U.S. Preventative Services Task Force.

Several reasons might explain the reluctance, such as competing demands and limited time to properly assess a patient's eligibility for aspirin, according to lead author Kevin A. Fiscella, M.D., M.P.H., professor of Family Medicine at the UR School of Medicine and Dentistry.

Uncertainty about the benefits of aspirin therapy versus potential harms like bleeding in the digestive track, also hinder physicians' decisions, the study said.

For the JGIM study, Fiscella's group analyzed data from 3,439 patients included in the 2011-'12 National Health and Nutrition Examination Survey (NHANES). None of the patients had cardiovascular disease, but all qualified for based on their 10-year risk score for factors such as diabetes, , obesity, smoking, and use of cholesterol-lowering medications.

Of the sample, 87 percent of men and 16 percent of women were eligible to take aspirin as a preventive measure. But when they were asked the question—"Doctors and other sometimes recommend that you take a low-dose aspirin each day to prevent , strokes, or cancer. Have you ever been told to do this?"—a low rate of 34 percent of the men and 42 percent of the women said yes.

Co-author John Bisognano, M.D., Ph.D., director of outpatient cardiology services at UR Medicine, said most physicians can agree on approaches to medical care in immediately life-threatening situations, but have less enthusiasm to quickly embrace preventive guidelines, particularly when they involve wide-ranging interventions for a large segment of the population.

New studies that present conflicting data or re-interpret older data also complicate the issue and can be confusing for patients, he said. Despite the USPSTF guidelines for aspirin being published in 2009, for example, the FDA declined to approve the same recommendations as recently as last spring.

"Patients often view changes as an illustration that folks in the medical field can't really make up their minds," said Bisognano, professor of Medicine. "Changes can undermine a practitioner's or patient's enthusiasm to immediately endorse new guidelines because they wonder if it will change again in three years."

But science and medical practice is fluid, he said, and the only way to move the field forward is to continually understand and look for ways to apply the new data and avoid assumptions of the past.

The study also noted that using expanded primary care teams of nurses, medical assistants, and health educators may help to reduce the volume of decisions that rest solely with the physician at the office visit. Sharing care can improve agreement between published guidelines, the use of risk models, and actual practice, the study said.

Explore further: Many at-risk heart disease patients lack guidance on beneficial aspirin treatment

More information: Journal of General Internal Medicine, link.springer.com/article/10.1 … 07/s11606-014-2985-8

Related Stories

Many at-risk heart disease patients lack guidance on beneficial aspirin treatment

July 15, 2014
(Medical Xpress)—A daily low dose of aspirin can offer important protection against cardiovascular disease, but University of Florida researchers say that the people who could receive the most benefit from the medication ...

Daily aspirin regimen not safe for everyone, FDA warns

May 6, 2014
(HealthDay)—Taking an aspirin a day can help prevent heart attack and stroke in people who have suffered such health crises in the past, but not in people who have never had heart problems, according to the U.S. Food and ...

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added

June 6, 2013
While aspirin has been shown to be effective in preventing heart attacks in men, it also increases the risk of gastrointestinal bleeding and possibly stroke, even at low doses. As such, national guidelines suggest that aspirin ...

Aspirin not always best treatment for many individuals

May 16, 2013
(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as they assess whether ...

More Americans working to control blood pressure, cholesterol

May 29, 2014
(HealthDay)—Although more Americans are trying to lower their blood pressure and cholesterol levels, more needs to be done to reduce the number of heart attacks and strokes in the United States, government health officials ...

2014 ESC/ESA Guidelines on non-cardiac surgery: Cardiovascular assessment and management

August 1, 2014
The publication of the new joint ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management introduces a number of recommendations in the field. Among other topics, the Guidelines include updated ...

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

countusin2
not rated yet Aug 05, 2014
of course they don't. no one is paying them to recommend aspirin. Doctors are all about kickbacks. if the oil companies would pay them they would prescribe gasoline...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.